Evidence map›Paper›PMID 24627472›Full record

ArticleThe Journal of biological chemistry2014

Molecular basis for impaired DNA damage response function associated with the RAP80 ΔE81 defect.

Anamika, Craig J Markin, Manoj K Rout, Leo Spyracopoulos

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. RAP80, ubiquitin and SUMO in the DNA damage response.Journal of molecular medicine (Berlin, Germany) · 2017
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

AnamikaFrom the Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada.
Craig J Markin
Manoj K Rout
Leo Spyracopoulos
University of Alberta · CA

Funding

Canadian Institutes of Health Research MOP 110964
6 · The paper itself

Abstract

Signal transduction within the DNA damage response is driven by the flux of protein-protein interaction cascades that ultimately recruit repair complexes to sites of damage. The protein RAP80 plays a central role in the damage response by targeting BRCA1/BRCA2 tumor suppressors to DNA damage foci through multivalent binding of Lys-63-linked polyubiquitin chains. Mutations within the high penetrance BRCA1/BRCA2 genes account for ∼20% of familial breast cancers. The genetic basis for the remaining cancers remains unknown, but may involve defects in binding partners for BRCA1 and BRCA2 that lead to impaired targeting to foci and a concomitant role in the pathogenesis of cancer. Recently, an in-frame deletion mutation (ΔE81) in a conserved region from the first ubiquitin interaction motif of RAP80 has been linked to an increase in chromosomal abnormalities. Using NMR spectroscopy, we demonstrate that the N-cap motif within the α-helix of the first ubiquitin interaction motif from ΔE81 undergoes a structural frameshift that leads to abolishment of multivalent binding of polyubiquitin chains. Loss of this single glutamate residue disrupts favorable electrostatic interactions between RAP80 and ubiquitin, establishing a plausible molecular basis for a potential predisposition to cancer unrelated to mutations within BRCA1/BRCA2 genes.

Indexed as

DNA DamageMutationAlgorithmsBinding SitesCarrier ProteinsDNA-Binding ProteinsDNA RepairHistone ChaperonesHumansKineticsMagnetic Resonance SpectroscopyModels, ChemicalModels, MolecularNuclear ProteinsProtein BindingProtein Structure, SecondaryCarrier ProteinsDNA-Binding ProteinsHistone ChaperonesNuclear ProteinsUbiquitinUIMC1 protein, humanBiophysicsDNA Damage ResponseNMRProtein-Protein InteractionsUbiquitination

Identifiers

PMID24627472
PMCPMC4007473
OpenAlexW1967411550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.